| Autor: |
Hu, Danrong, Li, Yicong, Li, Ran, Wang, Meng, Zhou, Kai, He, Chengqi, Wei, Quan, Qian, Zhiyong |
| Předmět: |
|
| Zdroj: |
Acta Pharmaceutica Sinica B; Dec2024, Vol. 14 Issue 12, p5106-5131, 26p |
| Abstrakt: |
Reactive oxygen species (ROS)-responsive drug delivery systems (DDSs) have garnered significant attention in cancer research because of their potential for precise spatiotemporal drug release tailored to high ROS levels within tumors. Despite the challenges posed by ROS distribution heterogeneity and endogenous supply constraints, this review highlights the strategic alliance of ROS-responsive DDSs with photodynamic therapy (PDT), enabling selective drug delivery and leveraging PDT-induced ROS for enhanced therapeutic efficacy. This review delves into the biological importance of ROS in cancer progression and treatment. We elucidate in detail the operational mechanisms of ROS-responsive linkers, including thioether, thioketal, selenide, diselencide, telluride and aryl boronic acids/esters, as well as the latest developments in ROS-responsive nanomedicines that integrate with PDT strategies. These insights are intended to inspire the design of innovative ROS-responsive nanocarriers for enhanced cancer PDT. This review summarizes recent advances in reactive oxygen species-responsive drug delivery systems for photodynamic therapy, detailing strategies for targeted drug release and amplifying efficacy through photodynamic therapy-generated reactive oxygen species. [Display omitted] [ABSTRACT FROM AUTHOR] |
| Databáze: |
Supplemental Index |
| Externí odkaz: |
|
